Background: Deficits in motor performance and functional abilities represent a severe complication for individuals with steroid refractory chronic graft versus host disease (cGVHD) and is associated with decreased survival and high morbidity.
Objective: Characterize the impact of pomalidomide on motor and functional outcomes in patients with cGVHD.
Study Design: Thirty-four adult patients with cGVHD were enrolled in a randomized and unblinded trial.